On August 16, 2024, Michael Staffieri, Chief Operating Officer of DaVita Inc (NYSE:DVA), completed a sale of 42,119 shares of the company’s stock. The transaction was filed with the SEC on the same day. Following this sale, the insider now owns 209,365 shares of DaVita Inc.
DaVita Inc specializes in kidney treatment and dialysis services and operates a network of outpatient dialysis centers throughout the United States. The company is known for providing a range of dialysis treatments and supportive services, primarily for patients suffering from chronic or end-stage renal failure.
Over the past year, Michael Staffieri has sold a total of 71,607 shares and purchased no shares of the company’s stock. This latest transaction is part of a broader trend observed over the past year, when DaVita Inc. recorded a total of 8 insider sales and no insider purchases.
DaVita Inc.’s stock price was $150.13 on the day of the sale, giving the company a market capitalization of approximately $12.77 billion. The stock’s price-to-earnings ratio is 16.21, which is below both the industry median of 23.58 and the company’s historical median.
According to GF Value, DaVita Inc. currently has a price to GF Value ratio of 1.3, which suggests the stock is significantly overvalued. GF Value is calculated based on historical trading multiples, an adjustment factor from GuruFocus, and future business performance estimates from analysts.
This insider sale may be of interest to investors who follow insider behavior as an indicator of company performance and valuation prospects.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
